Biomarkers of cardiac fibrosis in arterial hypertension

Biomarkers of cardiac fibrosis in arterial hypertension

The article presents a review of the literature on the role of myocardial fibrosis in the development of myocardial remodeling in patients with arterial hypertension. Information about the state of the structure and function of the extracellular matrix in health and disease is generalized. The chara...

Full description

Bibliographic Details
Main Authors:	N. Ya. Dotsenko, L. V. Gerasimenko, S. S. Boev, I. A. Shekhunova, A. V. Molodan, A. Ya. Malinovskaya, O. V. Yatsenko
Format:	Article
Language:	English
Published:	Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine 2020-12-01
Series:	Сучасні медичні технології
Subjects:	arterial hypertension myocardial fibrosis extracellular matrix collagen biomarkers
Online Access:	https://zmapo-journal.com/index.php/journal/article/view/98

Similar Items

Variability of arterial hypertension as an additional factor to cardiovascular risk in atrial fibrillation
by: N. Ya. Dotsenko, et al.
Published: (2021-12-01)

Relationship between indicators of carotid artery rigidity and cognitive functions in arterial hypertension patients
by: N. Ya. Dotsenko, et al.
Published: (2019-04-01)

Research Progress of Myocardial Fibrosis and Atrial Fibrillation
by: Guangling Li, et al.
Published: (2022-07-01)

Lifestyle modification factors in hypertensive patients: impact on blood pressure variability
by: N. Ya. Dotsenko, et al.
Published: (2021-07-01)

Exploring Extracellular Matrix Crosslinking as a Therapeutic Approach to Fibrosis
by: Sarah M. Lloyd, et al.
Published: (2024-03-01)

Changes in extracellular matrix in subcutaneous small resistance arteries of patients with essential hypertension
by: Gaia Favero, et al.
Published: (2018-07-01)

Diverse functions of matrix metalloproteinases during fibrosis
by: Matthew Giannandrea, et al.
Published: (2014-02-01)

INTERRELATION BETWEEN SUBCLINICAL STRUCTURAL CHANGES OF SLEEP ARTERY AND COGNITIVE FUNCTIONS IN PATIENTS WITH HYPERTENSION DISEASE
by: Dotsenko N. J., et al.
Published: (2018-05-01)

TECHNICAL, CLINICAL AND PROGNOSTIC ASPECTS OF HYPERTENSIVE RETINOPATHY
by: Dotsenko N. Ya., et al.
Published: (2020-12-01)

MECHANISMS FOR THE FORMATION MYOCARDIAL FIBROSIS IN NORM AND IN CERTAIN CARDIOVASCULAR DISEASES, HOW TO DIAGNOSE IT
by: S. V. Miklishanskaya, et al.
Published: (2017-11-01)

Extracellular Matrix in Heart Disease: Focus on Circulating Collagen Type I and III Derived Peptides as Biomarkers of Myocardial Fibrosis and Their Potential in the Prognosis of Heart Failure: A Concise Review
by: Asparuh Nikolov, et al.
Published: (2022-03-01)

Biomarkers in patients with myocardial fibrosis
by: An Zhe, et al.
Published: (2017-10-01)

EFFECT OF ARTERIAL HYPERTENSION ON LEFT VENTRICULAR GEOMETRIC REMODELING AND LEFT ATRIAL MECHANICAL DYSFUNCTION IN ATRIAL FIBRILLATION
by: M. Ya. Dotsenko, et al.
Published: (2022-06-01)

Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis
by: Mark G Jones, et al.
Published: (2018-07-01)

Role of the cardiac extracellular matrix in the onset and progression of heart failure
by: N. N. Ilov, et al.
Published: (2021-07-01)

Remodeling and Fibrosis of the Cardiac Muscle in the Course of Obesity—Pathogenesis and Involvement of the Extracellular Matrix
by: Jagoda Kruszewska, et al.
Published: (2022-04-01)

Effect of exogenous adiponectin on myocardial fibrosis in mice models with myocardial fibrosis
by: Feng-Lin Jin, et al.
Published: (2016-01-01)

Cell–Matrix Interactions in Renal Fibrosis
by: Kristin P. Kim, et al.
Published: (2022-12-01)

Multifunctional biomaterial platforms for blocking the fibrosis process and promoting cellular restoring effects in myocardial fibrosis therapy
by: Tian Yue, et al.
Published: (2022-09-01)

Concentration-Dependent Attenuation of Pro-Fibrotic Responses after Cannabigerol Exposure in Primary Rat Hepatocytes Cultured in Palmitate and Fructose Media
by: Klaudia Sztolsztener, et al.
Published: (2023-09-01)

Irreversible Bladder Remodeling Induced by Fibrosis
by: Su Jin Kim, et al.
Published: (2021-05-01)

Wilms Tumor 1-Driven Fibroblast Activation and Subpleural Thickening in Idiopathic Pulmonary Fibrosis
by: Prathibha R. Gajjala, et al.
Published: (2023-02-01)

Fibrosis in Mesothelioma: Potential Role of Lysyl Oxidases
by: Lara Perryman, et al.
Published: (2022-02-01)

Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis
by: Liang Shan, et al.
Published: (2023-05-01)

LPA1 antagonist BMS-986020 changes collagen dynamics and exerts antifibrotic effects in vitro and in patients with idiopathic pulmonary fibrosis
by: Benjamin E. Decato, et al.
Published: (2022-03-01)

Endotrophin is a risk marker of complications in CANagliflozin cardioVascular Assessment Study (CANVAS): a randomized controlled trial
by: Daniel Guldager Kring Rasmussen, et al.
Published: (2022-11-01)

Effects of Quercetin on Cardiac Fibrosis in Patients with Acute Myocardial Infarction and Arterial Hypertension
by: Wael Rumaneh, et al.
Published: (2017-06-01)

Editorial: Myocardial fibrosis: What we know now
by: Gabriela Kania, et al.
Published: (2023-01-01)

The Extracellular Matrix Enriched With Exosomes for the Treatment on Pulmonary Fibrosis in Mice
by: Yanzhen Yu, et al.
Published: (2021-12-01)

The Versatile Role of Matrix Metalloproteinase for the Diverse Results of Fibrosis Treatment
by: Hong-Meng Chuang, et al.
Published: (2019-11-01)

Elevated Alpha 1(I) to Alpha 2(I) Collagen Ratio in Dermal Fibroblasts Possibly Contributes to Fibrosis in Systemic Sclerosis
by: Soichiro Sawamura, et al.
Published: (2022-06-01)

Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis
by: Gavin Tjin, et al.
Published: (2017-11-01)

Endotrophin, a fibroblast matrikine, may be a driver of fibroblast activation in fibro-inflammatory diseases
by: Alexander L. Reese-Petersen, et al.
Published: (2023-07-01)

Comment on “Scar‐Degrading Endothelial Cells as a Treatment for Advanced Liver Fibrosis”
by: David M. Dolivo, et al.
Published: (2023-06-01)

MiR-144-3p Enhances Cardiac Fibrosis After Myocardial Infarction by Targeting PTEN
by: Xiaolong Yuan, et al.
Published: (2019-10-01)

Lack of Relationship between Fibrosis-Related Biomarkers and Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis in Dilated Cardiomyopathy
by: Paweł Rubiś, et al.
Published: (2021-05-01)

Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
by: Xiaoying Yin, et al.
Published: (2023-03-01)

microRNA are central players in anti- and profibrotic gene regulation during liver fibrosis.
by: Andrea eNoetel, et al.
Published: (2012-03-01)

Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis
by: Henrik Jessen, et al.
Published: (2021-11-01)

The role of the structural fibrosis markers in the left atrial remodeling in patients with paroxymal atrial fibrillation
by: A. I. Gozhenko, et al.
Published: (2017-02-01)